Oncocross Co. Ltd. Engages in Biopharmaceutical research services. The company was founded in July 2015 and is headquartered in Seoul, South Korea.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

“NEO CREMAR” is a professional manufacturer of functional food ingredients and food additives, contributing to the qualitative improvement of food. Based on more than 20 years of history, “NEO CREMAR” maintains domestic and overseas branch offices and supplies functional food materials of the highest quality through systematic technical sales and continuous R&D and investments.

Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

CAVΛDIS™ is a Dutch biomedical company active in the field of cardiovascular risk assessment. They develop prognostic tests to identify patients at risk of cardiovascular and disease. The company identified several novel biomarkers predictive for cardiovascular events. It is their goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.

Les h��pitaux universitaires de Gen��ve is a private company headquartered in Switzerland that operates hospitals.

MaxiVAX is a Swiss clinical-stage biotechnology company, currently performing a first-in-man (phase I) trial in various tumours with MVX-ONCO-1. MaxiVAX’ mission is to develop alternative solutions to “established cancer therapies” that are more effective, are personalized and enable the patient to fight his own disease. MaxiVAX’ first treatment, MVX-ONCO-1 has been classified as an Advanced Therapeutic Product by the European Medicines Agency. The resulting approval procedure is different than that of a traditional drug and should generally allow a faster development until market approval with fewer and less extensive clinical trials.

TOYO SHINYAKU Co., Ltd. engages in the consigned manufacture and sale of health food products, medicines, cosmetics, ingredients for quasi drugs and foshu products. The company was founded on March 19, 1993 and is headquartered in Fukuoka, Japan.

Vestion, Inc. is an American private company located in Miami, FL. The firm provides healthcare services. It was founded by Joshua M. Hare.

Green Cross Wellbeing produces wellness injection, nutritional injection drug, health functional foods, natural materials and pharmaceuticals, and other related products. GC Wellbeing is a newly launched company that merged the three divisions: the WB division of Green Cross, which was in charge of the sales of well-being injections, Green Cross JBP, a producer of nutritional injection drugs such as placental injections, and Green Cross HS, which specializes in the development of natural materials and medicine.

UPSIDE Foods (formerly known as Memphis Meats) develops meat produced directly from animal cells without the need to raise and slaughter actual animals. This approach requires significantly less water, land, and energy than conventional meat production, enabling consumers to enjoy meat that is clean, humane, and free of harmful chemicals. Co-founded and led by Dr. Uma Valeti in 2015, UPSIDE Foods is headquartered in Berkeley, California.

CYTOO focuses on innovative products for the life science research market with an emphasis in cell based assays, high content analysis and cell screening. They develop, manufacture, and distribute products that make cellular analysis robust and reliable by dramatically decreasing cell variability. There new micropattern-based products are designed to meet the needs of all clients whatever their research goals. They are open to suggestions or specific requests that can improve and spread the scope of this breakthrough in quantitative cell analysis.

Lifecord, Inc. Corp. is a South Korean private company. The firm provides research and experimental development on medical sciences and pharmacy products.

Aleph Farms is an Israel-based food technology company designing new ways to grow quality animal products that improve sustainability, food security and animal welfare in our food systems. Founded in 2017, the company utilized cellular agriculture technology to unveil the world’s first cultivated thin-cut steak in 2018, the world’s first cultivated ribeye steak in 2021, and cultivated collagen in 2022. Under its product brand, Aleph Cuts, the company will launch its first product, the Petit Steak, grown from the non-modified cells of a premium Angus cow. For its contributions to climate leadership including a net zero commitment made in 2020, it has received top accolades from the World Economic Forum and the United Nations.

Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.